Paulina Hill joined Polaris in 2012 and focuses on investments in healthcare from the Boston office.
Paulina serves on the boards of Arsenal Medical, Faraday Pharmaceuticals, Kala Pharmaceuticals (NASDAQ:KALA), KinDex Pharmaceuticals, Marauder Therapeutics and NeuroStar. She is an observer on the boards of 480 Biomedical, Microchips Biotech and Sofregen.
In addition to her investing role, Paulina has served as founding CEO of Polaris-backed Marauder Therapeutics, a biotech startup based in Cambridge, MA. She also serves on the board of The Capital Network, a non-profit that provides fundraising education to startup entrepreneurs.
Prior to joining Polaris, Paulina completed her postdoctoral fellowship in the Chemical Engineering department at MIT in Bob Langer’s lab. Paulina is the founding President of the MIT Postdoctoral Association and served on the MIT Intellectual Property Presidential Committee.
Paulina completed her PhD in Molecular Medicine with a Tissue Engineering focus at Wake Forest University School of Medicine. Paulina graduated magna cum laude from East Carolina University with a quadruple major in biochemistry, neuroscience, biology and chemistry. ECU honored Paulina with the Incredible Women’s award in 2017.
Paulina was born in Poland and grew up in Toronto. She attended East Carolina on an athletic scholarship, serving as Captain of the women’s tennis team.